Drake & Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$552K Sell
6,395
-1,062
-14% -$93.6K 0.09% 71
2026
Q2
$583K Sell
7,457
-5,394
-42% -$435K 0.1% 66
2026
Q1
$1.11M Sell
12,851
-5,287
-29% -$506K 0.21% 43
2025
Q4
$1.74M Sell
18,138
-9,780
-35% -$950K 0.35% 35
2025
Q3
$2.52M Buy
+27,918
New +$2.57M 0.53% 32

Other funds holding MDT

Drake & Associates's MDT Position: Q3 2026 in Review

Drake & Associates reduced its Medtronic (MDT) stake by 14% in Q3 2026, selling an estimated $93.6K and leaving 6,395 shares worth $552K. The position accounts for 0.09% of the portfolio, ranked #71.

Drake & Associates first reported a position in MDT in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.52M in Q3 2025. 2,202 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Drake & Associates held 6,395 shares of Medtronic worth $552K as of Q3 2026.
  • Drake & Associates sold 1,062 Medtronic shares in Q3 2026, an estimated $93.6K.
  • Medtronic made up 0.09% of Drake & Associates's portfolio in Q3 2026, its #71 holding.
  • Drake & Associates first reported a position in Medtronic in Q3 2025 and has held it in 5 quarters since.
  • Drake & Associates's Medtronic position peaked at $2.52M in Q3 2025.
  • 2,202 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Drake & Associates's 13F filing for Q3 2026, filed 18 Nov 2026.